Lakefront Biotherapeutics (LKFT) EBIT Margin (2014 - 2026)
Lakefront Biotherapeutics (LKFT) posted EBIT Margin of -358.92% for the quarter ended Jun 30, 2026, down 271.67 percentage points from -87.25% a year earlier but up 624.00 percentage points from the prior quarter.
Lakefront Biotherapeutics (LKFT) EBIT Margin (2014 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBIT Margin at Lakefront Biotherapeutics was 40.59%, up 139.65 percentage points year-over-year; for the year ended Dec 31, 2025, it came in at 26.53%, up 94.85 percentage points from the prior year.
- Annual EBIT Margin shows a five-year change of +63.89 percentage points (years ended Dec 2020 to Dec 2025).
- In prior years, Lakefront Biotherapeutics' EBIT Margin was -68.33% in the year ended Dec 31, 2024 (-31.51 pp), -36.82% in the year ended Dec 31, 2023 (+17.51 pp), -54.32% in the year ended Dec 31, 2022 (+18.88 pp) and -73.20% in the year ended Dec 31, 2021 (-35.83 pp).
- Quarterly EBIT Margin has run from a low of -982.92% in the quarter ended Mar 31, 2026 to a high of 190.13% in the quarter ended Dec 31, 2024 over five years.
- On a year-over-year basis, EBIT Margin has declined in each of the last four quarters, with an average year-over-year change of -211.53 percentage points over the last seven quarters.
- The strongest year-over-year quarter for EBIT Margin in the past five years was the quarter ended Dec 31, 2024, with a gain of 150.17 percentage points; the weakest was the quarter ended Mar 31, 2026, with a drop of 771.24 percentage points.
- According to Business Quant data, EBIT Margin for the three prior quarters was -982.92% (quarter ended Mar 31, 2026), 84.06% (quarter ended Dec 31, 2025) and -346.51% (quarter ended Sep 30, 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 28.37% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 37.40% |
| 10 | Lakefront Biotherapeutics | 1.97 Bn | 1.97 Bn | 3.51 Mn | -358.92% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -358.92% |
| Mar 31, 2026 | -982.92% |
| Dec 31, 2025 | 84.06% |
| Sep 30, 2025 | -346.51% |
| Jun 30, 2025 | -87.25% |
| Mar 31, 2025 | -211.68% |
| Dec 31, 2024 | 190.13% |
| Sep 30, 2024 | -119.07% |
| Mar 31, 2024 | -53.07% |
| Dec 31, 2023 | 39.96% |
| Sep 30, 2023 | -23.23% |
| Jun 30, 2023 | -22.49% |
| Mar 31, 2023 | -24.24% |
| Sep 30, 2022 | -27.58% |
| Jun 30, 2022 | -55.47% |
| Mar 31, 2022 | -15.51% |
| Sep 30, 2021 | -55.27% |
| Jun 30, 2021 | -33.45% |
| Mar 31, 2021 | -44.60% |
| Dec 31, 2020 | -33.68% |
Lakefront Biotherapeutics EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=LKFT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "LKFT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=LKFT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();